Eversept Partners, LP Danaher Corp Transaction History

Eversept Partners, LP

  • $1.26 Billion
  • Q3 2024

A detailed history of Eversept Partners, LP transactions in Danaher Corp stock. As of the latest transaction made, Eversept Partners, LP holds 38,429 shares of DHR stock, worth $8.81 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
38,429
Previous 40,855 5.94%
Holding current value
$8.81 Million
Previous $10.2 Million 4.65%
% of portfolio
0.85%
Previous 0.77%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$239.25 - $280.76 $580,420 - $681,123
-2,426 Reduced 5.94%
38,429 $10.7 Million
Q1 2024

May 15, 2024
SELL
$224.58 - $256.19 $41,771 - $47,651
-186 Reduced 0.45%
40,855 $10.2 Million
Q4 2023

Feb 14, 2024
SELL
$185.1 - $233.13 $11.6 Million - $14.6 Million
-62,743 Reduced 60.46%
41,041 $9.49 Million
Q3 2023

Nov 14, 2023
BUY
$233.08 - $265.59 $102,322 - $116,594
439 Added 0.42%
103,784 $25.7 Million
Q2 2023

Nov 08, 2023
SELL
$224.99 - $256.14 $10.2 Million - $11.6 Million
-45,340 Reduced 30.49%
103,345 $24.8 Million
Q2 2023

Aug 14, 2023
SELL
$224.99 - $256.14 $10.2 Million - $11.6 Million
-45,340 Reduced 30.49%
103,345 $24.8 Million
Q1 2023

Nov 08, 2023
SELL
$239.75 - $277.0 $3.33 Million - $3.85 Million
-13,886 Reduced 8.54%
148,685 $37.5 Million
Q1 2023

May 15, 2023
SELL
$239.75 - $277.0 $3.33 Million - $3.85 Million
-13,886 Reduced 8.54%
148,685 $37.5 Million
Q4 2022

Nov 08, 2023
BUY
$241.42 - $282.29 $6,035 - $7,057
25 Added 0.02%
162,571 $43.2 Million
Q4 2022

Feb 14, 2023
BUY
$241.42 - $282.29 $6,035 - $7,057
25 Added 0.02%
162,571 $43.2 Million
Q3 2022

Nov 08, 2023
SELL
$247.06 - $1507.4 $4.23 Million - $25.8 Million
-17,113 Reduced 9.53%
162,546 $42 Million
Q3 2022

Nov 14, 2022
SELL
$247.06 - $1507.4 $4.23 Million - $25.8 Million
-17,113 Reduced 9.53%
162,546 $42 Million
Q2 2022

Nov 08, 2023
BUY
$237.11 - $299.66 $4.72 Million - $5.96 Million
19,891 Added 12.45%
179,659 $45.5 Million
Q2 2022

Aug 15, 2022
BUY
$237.11 - $299.66 $4.72 Million - $5.96 Million
19,891 Added 12.45%
179,659 $45.6 Million
Q1 2022

Nov 08, 2023
BUY
$257.27 - $315.76 $14.5 Million - $17.8 Million
56,423 Added 54.6%
159,768 $46.9 Million
Q1 2022

May 16, 2022
SELL
$257.27 - $315.76 $2.65 Million - $3.25 Million
-10,285 Reduced 6.05%
159,768 $46.9 Million
Q4 2021

Nov 08, 2023
BUY
$292.08 - $329.01 $6.46 Million - $7.28 Million
22,115 Added 14.95%
170,053 $55.9 Million
Q4 2021

Feb 14, 2022
BUY
$292.08 - $329.01 $6.46 Million - $7.28 Million
22,115 Added 14.95%
170,053 $56 Million
Q3 2021

Nov 08, 2023
SELL
$272.21 - $332.43 $15.5 Million - $18.9 Million
-56,767 Reduced 27.73%
147,938 $45 Million
Q3 2021

Nov 15, 2021
SELL
$272.21 - $332.43 $15.5 Million - $18.9 Million
-56,767 Reduced 27.73%
147,938 $45.1 Million
Q2 2021

Nov 08, 2023
BUY
$225.08 - $271.69 $6.12 Million - $7.38 Million
27,171 Added 15.3%
204,705 $54.9 Million
Q2 2021

Aug 16, 2021
BUY
$225.08 - $271.69 $6.12 Million - $7.38 Million
27,171 Added 15.3%
204,705 $55 Million
Q1 2021

Nov 08, 2023
BUY
$212.38 - $245.9 $10.9 Million - $12.6 Million
51,204 Added 40.53%
177,534 $40 Million
Q1 2021

May 13, 2021
BUY
$212.38 - $245.9 $10.9 Million - $12.6 Million
51,204 Added 40.53%
177,534 $40 Million
Q4 2020

Nov 08, 2023
BUY
$212.5 - $245.46 $4.88 Million - $5.64 Million
22,985 Added 22.24%
126,330 $28.1 Million
Q4 2020

Feb 16, 2021
BUY
$212.5 - $245.46 $20.2 Million - $23.3 Million
94,970 Added 302.84%
126,330 $28.1 Million
Q3 2020

Nov 08, 2023
SELL
$177.16 - $215.33 $13.6 Million - $16.5 Million
-76,497 Reduced 70.92%
31,360 $6.75 Million
Q3 2020

Nov 13, 2020
SELL
$177.16 - $215.33 $13.6 Million - $16.5 Million
-76,497 Reduced 70.92%
31,360 $6.76 Million
Q2 2020

Nov 08, 2023
SELL
$128.7 - $176.83 $16.2 Million - $22.3 Million
-126,100 Reduced 53.9%
107,857 $19.1 Million
Q2 2020

Aug 13, 2020
SELL
$128.7 - $176.83 $16.2 Million - $22.3 Million
-126,100 Reduced 53.9%
107,857 $19.1 Million
Q1 2020

Nov 08, 2023
BUY
$121.39 - $169.05 $4.47 Million - $6.23 Million
36,850 Added 18.7%
233,957 $32.4 Million
Q1 2020

May 13, 2020
BUY
$121.39 - $169.05 $4.47 Million - $6.23 Million
36,850 Added 18.7%
233,957 $32.4 Million
Q4 2019

Nov 08, 2023
BUY
$133.47 - $153.48 $2.46 Million - $2.82 Million
18,403 Added 10.3%
197,107 $30.3 Million
Q4 2019

Feb 13, 2020
BUY
$133.47 - $153.48 $2.46 Million - $2.82 Million
18,403 Added 10.3%
197,107 $30.3 Million
Q3 2019

Nov 08, 2023
BUY
$135.4 - $146.47 $4.55 Million - $4.92 Million
33,600 Added 23.16%
178,704 $25.8 Million
Q3 2019

Nov 13, 2019
BUY
$135.4 - $146.47 $4.55 Million - $4.92 Million
33,600 Added 23.16%
178,704 $25.8 Million
Q2 2019

Nov 08, 2023
SELL
$124.88 - $143.73 $1.71 Million - $1.96 Million
-13,660 Reduced 8.6%
145,104 $20.7 Million
Q2 2019

Aug 13, 2019
SELL
$124.88 - $143.73 $1.71 Million - $1.96 Million
-13,660 Reduced 8.6%
145,104 $20.8 Million
Q1 2019

Nov 08, 2023
BUY
$97.62 - $132.29 $10.8 Million - $14.7 Million
110,960 Added 232.11%
158,764 $21 Million
Q1 2019

May 14, 2019
BUY
$97.62 - $132.29 $10.8 Million - $14.7 Million
110,960 Added 232.11%
158,764 $21 Million
Q4 2018

Nov 08, 2023
BUY
$94.85 - $109.54 $1.16 Million - $1.34 Million
12,200 Added 34.27%
47,804 $4.93 Million
Q4 2018

Feb 13, 2019
BUY
$94.85 - $109.54 $1.16 Million - $1.34 Million
12,200 Added 34.27%
47,804 $4.94 Million
Q3 2018

Nov 08, 2023
SELL
$98.13 - $108.9 $6.65 Million - $7.38 Million
-67,741 Reduced 65.55%
35,604 $3.87 Million
Q3 2018

Nov 14, 2018
BUY
$98.13 - $108.9 $3.49 Million - $3.88 Million
35,604 New
35,604 $3.87 Million

Others Institutions Holding DHR

# of Institutions
2,511
Shares Held
539M
Call Options Held
7.07M
Put Options Held
4.55M
View Full List

About DANAHER CORP

DHR Quotes by TradingView
  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $167B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Eversept Partners, LP Portfolio

Follow Eversept Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Eversept Partners, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email